ArticleScientific reports2026
An evaluation of a Bayesian method to track outbreaks of known and novel influenza-like illnesses.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
Tracking influenza and similar respiratory diseases is an important problem in public health and clinical medicine. The problem is complicated by the clinical similarity and co-occurrence of many of these illnesses. Additionally, recent history has shown that detecting new or reemergent diseases, such as COVID-19, is of paramount importance. This paper describes the design and testing of a system called ILI Tracker that is capable of tracking known influenza-like illnesses and early and accurately detecting the presence of a novel disease, such as COVID-19. We extracted clinical findings from 2.9M clinical records from five emergency departments using natural language processing. We constructed statistical models of six influenza-like illnesses for the first five years of the dataset and then used these models and a Bayesian filter to track the rates of these diseases in the five remaining years of data. We found significant daily correlation with the number of patients who were diagnosed with influenza and respiratory syncytial virus, but lower correlation with the other tracked diseases. We extended ILI Tracker to detect the presence of a novel, unmodeled disease, resulting in a strong signal near the beginning of the COVID-19 outbreak, and also in response to artificial injections of COVID-19 cases into case data streams, and known outbreaks of influenza and RSV treated as novel, unmodeled diseases. Our results suggest that ILI Tracker can detect the presence of a novel, unmodeled disease in a timely fashion with few false alarms. The ILI Tracker system is freely available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.